CEACAM5 and cancer: The current biomarkers for cancer diagnosis and prognosis assessment, such as carcinoembryonic antigen (CEA) and cancer antigen 19-9 (CA19-9), are hindered by their unsatisfactory specificity and sensitivity [83-85].